维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：期刊名="PharmacolRev"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Molecular aspects of ligand binding to serum albumin显示文摘	ULRICH K H	1981	PharmacolRev March1981，33，1：	1
2	Metabolism and dis- position kinetic of nicotine 显示文摘	Hukkanen J Jacob P 3rd Benowitz NL	2005	PharmacolRev2005，57，1：	1
3	Nitric oxide:physiology,pathophysiology and pharmacology显示文摘	Moncada S Palmer RM Higgs EA	1991	PharmacolRev1991，43，2：	1
4	The blood-brain barrier/neurovascular unit in health and disease显示文摘	Hawkins BT Davis TP	2005	PharmacolRev2005，57，2：	1
5	The blood-brain barrier/neuro- vascular unit in health and disease显示文摘	HAWKINS BT DAVIS TP	2005	PharmacolRev2005，57，2：	1
6	Actions of caffeine in the brain withspecialreference to factors that contribute to its widespresd use 显示文摘	Fredholm BB Battig K Holman J	1999	PharmacolRev1999，51，1：	1
7	Mechanism of antimicrobial peptide action and resistance显示文摘	Michael R	2003	PharmacolRev2003，55，1：	1
8	“Inside-out” signalingof sphingosine-1-phosphate : therapeutic targets显示文摘	Takabe K Paugh S W Milstien S	2008	PharmacolRev2008，60，2：	1
9	Pharmacological and clinical aspects of hemeoxygenase显示文摘	Abraham NG Kappas A	2008	PharmacolRev2008，60，1：	1
10	Cyclooxygenase isozymes : the bi-ology of prostaglandin synthesis and inhibition 显示文摘	Simmons DL Botting RM Hla T	2004	PharmacolRev2004，56，：	1
11	The blood-brain barrier/neurovascular unit inhealth and disease显示文摘	Hawkins BT Davis TP	2005	PharmacolRev2005，57，2：	1
12	Bioregulation ofkinins, kallikreins ,and kininases显示文摘	Figueroa CD Worthy K	1992	PharmacolRev1992，441，：	1
13	Structure and pharmacology of γaminobutyric acid: A receptor subtypes 显示文摘	Sieghart W	1995	PharmacolRev1995，47，2：	1
14	Potassium channels: Moleculardefects, diseases, and therapeutic opportunities显示文摘	Shieh CC Coghlan M Sullivan JP	2000	PharmacolRev2000，52，4：	1
15	The blood-testis barrier and its implications for male contraception显示文摘	Cheng C Y Mruk D D	2012	PharmacolRev2012，64，1：	1
16	Carbon monoxide:Endogenous prod- uction, physiological functions, and pharmacological appli- cations 显示文摘	WU L Y WANG R	2005	PharmacolRev2005，57，4：	1
17	Thearylhydrocarbonreceptorinbarrierorganphysiology,immunology, and toxicology显示文摘	EsserC RannugA	2015	PharmacolRev2015，67，2：	1
18	Contribution of kinins to the cardiovascular action of angiotensin converting enzyme inhibitors显示文摘	Lin ZW Wiemer G Gohike P	1995	PharmacolRev1995，47，：	1
19	Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition 显示文摘	SIMMONS DL BOTTING RM HLA T	2004	PharmacolRev2004，56，3：	1
20	Receptors for purines and pyrimidines显示文摘	Ralevic V Bumstock G	1998	PharmacolRev1998，50，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示